CORE-MD: Medical device registries for post-market surveillance
Release Date: 09/05/2024
AI4HF: Leveraging health informatics and epidemiologic data and methods for AI-based risk prediction and early intervention
Cardio Talk Latest Research
In this episode of Cardio Talk Latest Research, Machteld Boonstra from Amsterdam University Medical Centre interviews Dr. Kazem Rahimi, Professor of Cardiovascular Medicine and Population Health at the University of Oxford, about how leveraging existing large-scale population health data from registries and biobanks offers a valuable approach to training and validating AI models for the early detection of congestive heart failure (CHF) deterioration.
info_outline
AI4HF: Artificial intelligence implementation and implications in clinical practice
Cardio Talk Latest Research
With Machteld Boonstra, Amsterdam University Medical Centre, and Folkert Asselbergs, Amsterdam University Medical Centre - The Netherlands. Machteld Boonstra and Folkert Asselbergs discuss how artificial intelligence can be trustworthy in clinical practice, which is the aim of the AI4HF project. This podcast was recorded in September 2024.
info_outline
EHRA-PATHS Randomized trial: aim and importance
Cardio Talk Latest Research
With Isabelle van Gelder, Michiel Rienstra and Michelle Lobeek, University Medical Centre Groningen - The Netherlands, and Prash Sanders, University of Adelaide - Australia. In this episode of Cardio Talk Latest Research, Isabelle van Gelder interviews Michiel Rienstra, Michelle Lobeek and Prash Sanders about the EHRA-PATHS clinical trial, which focuses on improving the quality of life for patients with atrial fibrillation and comorbidities. They discuss the clinical trial's design, methodology, and implementation in detail. This podcast was recorded in April 2024.
info_outline
AI4HF: Breaking Language Barriers in Healthcare: Exploring Multi-Lingual LLMs
Cardio Talk Latest Research
With Machteld Boonstra, Amsterdam University Medical Centre - The Netherlands, and Iker Garcia, HiTZ Basque Center for Language Technologies - Spain. In this episode of Cardio Talk Latest Research, Machteld Boonstra interviews Iker Garcia about multilingual large language models and their benefits. They discuss the limitations of these models in various languages, how to make them accessible to everyone, and the process of acquiring data to train these models. This podcast was recorded in February 2024.
info_outline
CARDIOCARE: cardiotoxicity in elderly breast cancer patients
Cardio Talk Latest Research
With Kalliopi Keramida, Agios Savvas General Oncology Hospital, Athens - Greece, and Dorothea Tsekoura, National and Kapodistrian University of Athens Medical School, Athens - Greece. In this episode of Cardio Talk Latest Research, Kalliopi Keramida and Dorothea Tsekoura discuss cardiotoxicity in elderly breast cancer patients. They note that breast cancer is now the most common form of cancer worldwide, with a strong correlation to aging. They explore studies focused on assessing cardiotoxicity in elderly patients with breast cancer. This podcast was recorded in October 2023.
info_outline
CORE-MD: Medical device registries for post-market surveillance
Cardio Talk Latest Research
With Alan Fraser, University Hospital of Wales, Cardiff - UK and Anne Lubbeke Wolff, University of Oxford - UK. In this episode of Cardio Talk Latest Research, Alan Fraser interviews Anne Lubbeke Wolff about the evidence supporting medical devices in Europe and the valuable lessons we can learn from the field of orthopedics. They explore the challenges surrounding transparency in device evaluation, the scarcity of literature on the pre-market phase, and the limitations of the post-market phase.
info_outline
CORE-MD: How do surgeons choose which medical device to implant?
Cardio Talk Latest Research
With Alan Fraser, University Hospital of Wales, Cardiff - UK, and Per Kjærsgaard-Andersen, European Federation of National Associations of Orthopaedics and Traumatology (EFORT) and Vejle Hospital - Denmark. In this episode of Cardio Talk Latest Research, Alan Fraser interviews Per Kjærsgaard-Andersen about how individual clinicians select and use high-risk medical devices on their patients daily, and what evidence they rely on when choosing which devices to use.
info_outline
CORE-MD: Real-world evidence on the performance of high-risk medical devices
Cardio Talk Latest Research
With Alan Fraser, University Hospital of Wales, Cardiff - UK, and Perla Marang-van de Mheen, Delft University of Technology - The Netherlands. In this episode of Cardio Talk Latest Research, Alan Fraser interviews Perla Marang-van de Mheen about the extensive range of real-world evidence available for monitoring high-risk medical devices after they reach the market. This podcast was recording in January 2024.
info_outline
CORE-MD: Providing medical devices for children
Cardio Talk Latest Research
With Alan Fraser, University Hospital of Wales, Cardiff - UK, and Berthold Koletzko, University of Munich - Germany. In this episode of Cardio Talk Latest Research, Alan Fraser interviews Berthold Koletzko about the use of medical devices in children. They discuss the reasons why children require medical devices and explore the challenges related to the availability and certification of these devices. This podcast was recorded in January 2024.
info_outline
CORE-MD: Understanding how notified bodies work in the European Union
Cardio Talk Latest Research
With Alan Fraser, University Hospital of Wales, Cardiff - UK, and Richard Holborow, BSI Group, Cardiff - UK. In this episode of Cardio Talk Latest Research, Alan Fraser interviews Richard Holborow to discuss the role of notified bodies both in CORE-MD project and within the broader European regulatory system. Richard Holborow provides a brief explanation of the functions and responsibilities of notified bodies. This podcast was recorded in January 2024.
info_outlineWith Alan Fraser, University Hospital of Wales, Cardiff - UK and Anne Lubbeke Wolff, University of Oxford - UK.
In this episode of Cardio Talk Latest Research, Alan Fraser interviews Anne Lubbeke Wolff about the evidence supporting medical devices in Europe and the valuable lessons we can learn from the field of orthopedics. They explore the challenges surrounding transparency in device evaluation, the scarcity of literature on the pre-market phase, and the limitations of the post-market phase.